Herceptin is primarily used to treat patients with HER2-positive breast cancer, a subtype that accounts for about 20-25% of all breast cancer cases. It can be used in both early-stage and metastatic breast cancer. Additionally, Herceptin is sometimes used to treat HER2-positive gastric cancer.
